Kathleen T. Brady, MD, PhD [email]
Principal Investigator

Medical University of South Carolina
Department of Psychiatry
67 President St., MSC 861
Charleston, SC 29425

Find Node Publications
Node web site
NIDA web site

The Southern Consortium Node (formerly the "South Carolina Node," renamed in 2005) joined the Clinical Trials Network in September 2000 and includes South Carolina, North Carolina, Georgia, Alabama, and Mississippi. The consortium was formed to help facilitate promulgation of CTN findings and provide a larger pool of potential CTN research sites. The CTPs of the Southern Consortium provide services to adults and adolescents in both rural and urban areas and represent a wide range of treatment settings and modalities including 12-step, family therapy, medication management, inpatient detoxification, drug court, narcotic replacement therapy, and cognitive behavioral therapy.


CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
CTN-0009 Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs
CTN-0011 A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities
CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
CTN-0015 Women's Treatment for Trauma and Substance Use Disorders
CTN-0016 Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment Settings
CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
CTN-0020 Job Seekers Training for Patients with Drug Dependence
CTN-0028 Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)
CTN-0028-A-1 Does Methylphenidate Treatment for ADHD Increase the Rate of Smoking in Adolescents with Comorbid ADHD, SUD, and Nicotine Dependence?

Prescription Opioid Addiction Treatment Study (POATS)

CTN-0030-A-1 Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
CTN-0032 HIV Rapid Testing and Counseling
CTN-0032-A-1 Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs
CTN-0037 Stimulant Reduction Intervention Using Dosed Exercise (STRIDE)
CTN-0037-A-1 Site Influences on Treatment Effects - Exercise as a Treatment for Substance Use Disorders
CTN-0046 Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence
CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
CTN-0049 Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)
CTN-0053 Achieving Cannabis Cessation -- Evaluating N-Acetylcystein Treatment (ACCESS)
CTN-0057 Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC)
CTN-0064 Linkage to Hepatitis C Virus (HCV) Care among HIV/HCV Co-infected Substance Users
CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2015 --